Tumor Microenvironment and Brain Metastases in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhang, Qin [1 ]
Fu, Xiaolong [1 ]
Cai, Xuwei [1 ]
Feng, Wen [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Radiat Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Tumor Budding; brain metastases; stage IIIA(N2) NSCLC; tumor-infiltrating lymphocytes;
D O I：
10.1016/j.jtho.2016.11.419
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA06.06
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [31] Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases
    Rong Qiao
    Runbo Zhong
    Jianlin Xu
    Yanwei Zhang
    Bo Zhang
    Shuyuan Wang
    Yuqing Lou
    Dongfang Chen
    Qing Chang
    Yizhuo Zhao
    Baohui Han
    Journal of Cardiothoracic Surgery, 14
  • [32] Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases
    Qiao, Rong
    Zhong, Runbo
    Xu, Jianlin
    Zhang, Yanwei
    Zhang, Bo
    Wang, Shuyuan
    Lou, Yuqing
    Chen, Dongfang
    Chang, Qing
    Zhao, Yizhuo
    Han, Baohui
    JOURNAL OF CARDIOTHORACIC SURGERY, 2019, 14 (1)
  • [33] Radiotherapy for patients with completely resected pathologic IIIA(N2) non-small-cell lung cancer: a retrospective analysis
    Zhu, Ying
    Fu, Lei
    Jing, Wang
    Kong, Li
    Yu, Jinming
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10901 - 10908
  • [34] Post-Operative Radiotherapy in completely resected Non-Small Cell Lung Cancer and N2 involvement
    Pires, A. M.
    Figueiredo, T.
    Conde, S.
    Ferreira, C.
    Laranja, A.
    de Castro, B.
    Sousa, F.
    Sarandao, S.
    Cardia, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S955 - S956
  • [35] Prognosis and Clinicopathologic Characteristics of Skip N2 Metastasis in Completely Resected Non-Small Cell Lung Cancer
    Tsuboi, T.
    Eriguchi, D.
    Nemoto, D.
    Samejima, J.
    Nagashima, T.
    Ito, H.
    Nakayama, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S551 - S551
  • [36] Adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Wang, S.
    Ou, W.
    Sun, H.
    Yang, H.
    Ye, X.
    Fang, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer
    Hu, Pin-Ching
    Huang, Jing-Yang
    Cheng, Ya-Fu
    Cheng, Ching-Yuan
    Huang, Chang-Lun
    Hung, Wei-Heng
    Wang, Bing-Yen
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] The Differential Impact of Postoperative Radiation Therapy for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer: Based on the Risk Prediction Model for Locoregional Recurrence
    Feng, W.
    Fu, X. L.
    Cai, X. W.
    Zhang, Q.
    Yu, W.
    Chen, H. Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S69 - S69
  • [39] Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it
    Zhang, Shu-Xian
    Zhang, Chen-Chen
    Hou, Run-Ping
    Cai, Xu-Wei
    Liu, Jun
    Yu, Wen
    Zhang, Qin
    Guo, Jin-Dong
    Wang, Chang-Lu
    Li, Hong-Xuan
    Zhu, Zheng-Fei
    Fu, Xiao-Long
    Feng, Wen
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 50
  • [40] Meta-analysis of prognostic factors of completely resected pathologic N2 stage IIIA non-small cell lung cancer including 11,384 patients
    Zhan, X.
    Li, N.
    ANNALS OF ONCOLOGY, 2018, 29 : 490 - 490
12345